HIGHLIGHTS
- who: Andi Ma and collaborators from the Institute of Physiology, Charitu00e9-Universitu00e4tsmedizin Berlin, Corporate Member of Freie Universitu00e4t Berlin, Organic Chemistry, University of Bayreuth, Universitu00e4tsstrasse, Bayreuth, Germany have published the Article: Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma, in the Journal: (JOURNAL)
- what: The authors further characterized the antineoplastic effects and modes of action of the two most promising inhibitors Thio-Iva and Thio-Dam and compared their effects with the clinically relevant multi-kinase inhibitor sorafenib in HCC cells.
- future: Future investigations of these promising kinase inhibitors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.